Astec Lifesciences Ltd (ASTEC) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 533138 | NSE: ASTEC | Pesticides & Agrochemicals | Small Cap

Astec Lifesciences Share Price

764 -54.20 -6.62%
as on 05-Dec'25 13:48

Astec Lifesciences Ltd (ASTEC) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 533138 | NSE: ASTEC | Pesticides & Agrochemicals | Small Cap

DeciZen - make an informed investing decision on Astec Lifesciences

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Astec Lifesciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (CD):
0.00
Market Cap:
1,823.1 Cr.
52-wk low:
608
52-wk high:
1,250.9

Is Astec Lifesciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Astec Lifesciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Astec Lifesciences Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.7%16.1%23.8%20.3%20.4%22.3%22.2%7.8%-4.5%-12.6%-
Value Creation
Index
-0.20.20.70.50.50.60.6-0.5-1.3-1.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 247299368431523555677628458381378
Sales YoY Gr.-20.9%23.1%17.2%21.3%6.2%21.9%-7.2%-27.1%-16.8%-
Adj EPS 2.39.69.217.522.231.842.210.1-25.5-69.7-51.1
YoY Gr.-324.7%-5.1%91.7%26.5%43.3%32.9%-76.1%-352%NA-
BVPS (₹) 59.969.985.8102.4124.8156.5200.7212.2186.8118.8185.8
Adj Net
Profit
4.518.91834.643.762.783.420-50.3-138-114
Cash Flow from Ops. -12.519.264.715.3168-8.223.674.710.2-8.4-
Debt/CF from Ops. -10.16.61.911.50.6-22.911.84.648.3-66-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.9%-6.1%-17.4%-16.8%
Adj EPS -246.3%-225.7%-218.2%NA
BVPS7.9%-1%-16.1%-36.4%
Share Price 12.2% -4.7% -26.8% -29.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.514.811.718.619.522.623.64.9-12.8-45.6-33.6
Op. Profit
Mgn %
13.92118.717.816.320.122.812.2-1.3-17.4-4.7
Net Profit
Mgn %
1.86.44.988.411.312.33.2-11-36.1-30.1
Debt to
Equity
1.10.90.70.90.40.60.70.81.32.40.3
Working Cap
Days
304248233223217229244316379368175
Cash Conv.
Cycle
1059192956053102155224238-0

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Astec Lifesciences Ltd.

Standalone Consolidated
TTM EPS (₹) -51.2 -51.1
TTM Sales (₹ Cr.) 378 378
BVPS (₹.) 185.5 185.8
Reserves (₹ Cr.) 391 392
P/BV 4.41 4.40
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 608.00 / 1250.88
All Time Low / High (₹) 14.35 / 2269.11
Market Cap (₹ Cr.) 1,823
Equity (₹ Cr.) 22.3
Face Value (₹) 10
Industry PE 25.9

Management X-Ray of Astec Lifesciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Astec Lifesciences - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Astec Lifesciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales247299368431523555677628458381
Operating Expenses 215236299354437443522552464448
Manufacturing Costs19222532393852645459
Material Costs161180235279339342387401319297
Employee Cost 16202225303850526261
Other Costs 20141717302533352931
Operating Profit 326269768511115476-6-66
Operating Profit Margin (%) 12.8%20.9%18.7%17.7%16.3%20.1%22.8%12.1%-1.3%-17.4%
Other Income 73811128101366
Interest 131211121359212537
Depreciation 10141519232634343644
Exceptional Items -3-1140000000
Profit Before Tax 12295656618912135-62-141
Tax 71021201424319-15-6
Profit After Tax 519353648659026-47-135
PAT Margin (%) 2.1%6.4%9.5%8.3%9.1%11.7%13.3%4.1%-10.2%-35.3%
Adjusted EPS (₹)2.59.717.718.124.133.045.513.0-23.8-68.2
Dividend Payout Ratio (%)0%15%8%8%6%5%3%12%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 117137169202246309396419369235
Share Capital 19202020202020202020
Reserves 98118149182226289377399349215
Minority Interest0000000000
Debt11712612417699187239296482544
Long Term Debt8000040011199280
Short Term Debt10912612417699147239285283264
Trade Payables6857100632021281901778982
Others Liabilities 251320202453100873526
Total Liabilities 328334413461572678925979975887

Fixed Assets

Gross Block105124150221271316477488592749
Accumulated Depreciation1022355477103137170206250
Net Fixed Assets 95103115167194213340318386499
CWIP 2084219241162312716521
Investments 0000000000
Inventories71667893121106187295196160
Trade Receivables81111123122161187274155169147
Cash Equivalents 6411122223
Others Assets 554353597054100825757
Total Assets 328334413461572678925979975887

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -13196515168-8247510-8
PBT 12295656618912135-62-141
Adjustment 193518303729445163101
Changes in Working Capital -39-386-5588-103-112-61027
Tax Paid -5-7-15-16-18-23-29-5-25
Cash Flow From Investing Activity -16-18-49-52-74-73-104-113-135-15
Capex -26-20-50-53-45-103-104-116-135-16
Net Investments 820-00-0-0-0-0-0
Others 2010-29290401
Cash Flow From Financing Activity 31-1-1837-9581803812524
Net Proceeds from Shares 0000010000
Net Proceeds from Borrowing 000004001610590
Interest Paid -13-12-11-12-13-5-9-20-23-29
Dividend Paid -30-3-3-3-3-3-3-30
Others 4611-552-7948924546-38
Net Cash Flow 21-3-0000-0-00

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)4.0115.0722.919.3121.2423.4625.56.28-11.9-44.64
ROCE (%)10.6516.0823.7520.3120.4422.2922.217.75-4.5-12.62
Asset Turnover Ratio0.720.950.990.991.020.890.850.660.470.42
PAT to CFO Conversion(x)-2.611.860.423.5-0.120.272.88N/AN/A
Working Capital Days
Receivable Days13611111510398114124124129148
Inventory Days106807172747479139195167
Payable Days177127122107143176150167152105

Astec Lifesciences Ltd Stock News

Astec Lifesciences Ltd FAQs

The current trading price of Astec Lifesciences on 05-Dec-2025 13:48 is ₹764.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Astec Lifesciences stood at ₹1,823.1.
The latest P/E ratio of Astec Lifesciences as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Astec Lifesciences as of 04-Dec-2025 is 4.41.
The 52-week high of Astec Lifesciences is ₹1,250.9 and the 52-week low is ₹608.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Astec Lifesciences is ₹378.2 ( Cr.) .

About Astec Lifesciences Ltd

Astec is proud of its rich experience of over two decades in the chemical industry. The company employs highly qualified and trained personnel to monitor and maintain its manufacturing activities as well as process development work. Astec prides itself in being responsive, reliable and quick to implement projects. A strong R&D focus has enabled the company to introduce a number of unique products. As the operations are highly integrated both vertically and horizontally, Astec has a very efficient, low cost structure in the market place.

Strong emphasis on quality, backed by a highly competent technical team, has enabled Astec to establish a successful track record in nurturing stable and long term relationships with highly reputed companies in USA, Japan and Europe. Above all, utmost respect for confidentiality, reliability, integrity and commitment in all its business relationships make Astec an ideal outsourcing partner. Astec Chemicals operates an ISO 9001:2000 certified Quality Assurance system.

The company has technologically sophisticated facilities for process development work and has demonstrated its ability to synthesize complex molecules rapidly. All its laboratories are equipped to carry out reactions from gm-scale to kilo-scale {up to 20 litres}.

Scale up to multikilo level is undertaken at its versatile 50-500 lts capacity pilot plant. Setting up a feasibility study through to laboratory development, pilot scale-up and full scale production are governed by the highest safety, quality and environmental standards.

Astec has multipurpose production facilities at two locations.

• Dombivli (50 km from Mumbai) • Mahad - two plants ( 180 kms from Mumbai)

They are multi-purpose plants based on 3,000-20,000 litres glasslined and stainless steel reactors. Typical reactors sizes are 10,000 lts.

• The pilot plant has glass and SS vessels of 50 litres to 500 litres capacity. • Reactions can be carried out from minus 20o C to 250o C. Distillation up to 300C • Vacuum down to 1mm Hg. • Distillation systems can handle high melting solids. • High efficiency fractionating columns up to 40 theoretical plates are available. • Facilities are designed to handle a number of corrosive and hazardous raw materials.

Products:

• Tebuconazole • Hexaconazole • Propiconazole • Metalaxyl • 1,2 Pentanediol • Dicap • 4-Fluoro phenacyl chloride.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×